Header Logo

Connection

Michael Silverberg to United States

Back to Details
This is a "connection" page, showing publications Michael Silverberg has written about United States.
Michael Silverberg
Connection Strength
2.005
United States
  1. Dementia incidence and prevalence in older adults with HIV: a 23-year retrospective cohort study. AIDS. 2026 Apr 01; 40(4):486-495.
    View in: PubMed
    Score: 0.129
  2. Trends in Myocardial Infarction risk by HIV status in two U.S. healthcare systems. PLoS One. 2025; 20(6):e0325773.
    View in: PubMed
    Score: 0.125
  3. Comparison of dementia risk after age 50 between individuals with and without HIV infection. AIDS. 2021 04 01; 35(5):821-828.
    View in: PubMed
    Score: 0.093
  4. Beyond the HIV Care Continuum and Viral Suppression: Broadening the Scope of Quality Metrics for Total HIV Patient Care. AIDS Patient Care STDS. 2020 11; 34(11):461-469.
    View in: PubMed
    Score: 0.091
  5. Smoking and cessation treatment among persons with and without HIV in a U.S. integrated health system. Drug Alcohol Depend. 2020 08 01; 213:108128.
    View in: PubMed
    Score: 0.088
  6. Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States. Vaccine. 2020 01 03; 38(1):39-45.
    View in: PubMed
    Score: 0.084
  7. Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population. Public Health Rep. 2018 Jul/Aug; 133(4):452-460.
    View in: PubMed
    Score: 0.076
  8. The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System. AIDS Patient Care STDS. 2015 Nov; 29(11):582-90.
    View in: PubMed
    Score: 0.064
  9. Survey of video laryngoscopy use by U.S. critical care fellowship training programs. Ann Am Thorac Soc. 2014 Oct; 11(8):1225-9.
    View in: PubMed
    Score: 0.059
  10. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013 Mar 06; 105(5):350-60.
    View in: PubMed
    Score: 0.053
  11. Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. J Pain Symptom Manage. 2009 Aug; 38(2):197-207.
    View in: PubMed
    Score: 0.041
  12. Long-Acting Injectable Cabotegravir HIV PrEP Uptake, Adherence, and Persistence in Two Large US Integrated Healthcare Systems. J Acquir Immune Defic Syndr. 2026 Aug 01; 101(8):812-818.
    View in: PubMed
    Score: 0.034
  13. Effectiveness of highly-active antiretroviral therapy by race/ethnicity. AIDS. 2006 Jul 13; 20(11):1531-8.
    View in: PubMed
    Score: 0.034
  14. History of anxiety, depression, and post-traumatic stress disorder diagnoses among midlife and older transfeminine and transmasculine adults in the United States: A cross-sectional analysis within the STRONG cohort. J Affect Disord. 2026 Nov 01; 412:122180.
    View in: PubMed
    Score: 0.033
  15. Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study. Lancet HIV. 2026 May; 13(5):e297-e305.
    View in: PubMed
    Score: 0.033
  16. Changes in weight and glycemia after initiation of integrase strand transfer inhibitors among people with HIV and diabetes. AIDS. 2026 Aug 01; 40(8):1180-1189.
    View in: PubMed
    Score: 0.033
  17. Using Self-Identified Gender Identity Data to Advance Health Equity Among Transgender and Gender Diverse Veterans in the Veterans Health Administration. Med Care. 2025 11 01; 63(11):833-841.
    View in: PubMed
    Score: 0.032
  18. Pretransplant screening and lower incidence of breast and prostate cancers among organ transplant recipients in the United States. JNCI Cancer Spectr. 2025 Sep 01; 9(5).
    View in: PubMed
    Score: 0.032
  19. Life-years lost associated with mental disorders in people with HIV: a cohort study in South Africa, Canada and the United States. J Int AIDS Soc. 2025 Aug; 28(8):e70023.
    View in: PubMed
    Score: 0.031
  20. Sociodemographic and clinical factors associated with use of depression treatment among people with HIV in the United States: An electronic health records-based cohort study. J Affect Disord. 2025 Dec 01; 390:119815.
    View in: PubMed
    Score: 0.031
  21. The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD. J Acquir Immune Defic Syndr. 2024 Nov 01; 97(3):232-241.
    View in: PubMed
    Score: 0.030
  22. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Sep 01; 39(5):717-24.
    View in: PubMed
    Score: 0.029
  23. Life and Disability Insurance for People with or at Risk of HIV: Aligning Policy with Evidence. J Insur Med. 2024 Jul 01; 51(1):25-28.
    View in: PubMed
    Score: 0.029
  24. Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants. Am J Epidemiol. 2004 Feb 01; 159(3):232-41.
    View in: PubMed
    Score: 0.028
  25. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study. PLoS Med. 2024 Jan; 21(1):e1004325.
    View in: PubMed
    Score: 0.028
  26. Timing and completeness of routine testing for antibodies to human immunodeficiency virus type 1 among active duty members of the U.S. Armed Forces. Mil Med. 2003 Feb; 168(2):160-4.
    View in: PubMed
    Score: 0.026
  27. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. JAMA. 2023 01 03; 329(1):52-62.
    View in: PubMed
    Score: 0.026
  28. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis. 2002 Aug; 29(8):427-35.
    View in: PubMed
    Score: 0.026
  29. Longitudinal HIV care outcomes by gender identity in the United States. AIDS. 2022 11 01; 36(13):1841-1849.
    View in: PubMed
    Score: 0.026
  30. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States. JAMA Netw Open. 2022 06 01; 5(6):e2215934.
    View in: PubMed
    Score: 0.025
  31. Treatment for alcohol use disorder among persons with and without HIV in a clinical care setting in the United States. Drug Alcohol Depend. 2021 12 01; 229(Pt A):109110.
    View in: PubMed
    Score: 0.024
  32. Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. AIDS. 2021 07 01; 35(8):1229-1239.
    View in: PubMed
    Score: 0.024
  33. Repeat positive severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) testing =90 days apart in pregnant women. Am J Obstet Gynecol MFM. 2021 05; 3(3):100331.
    View in: PubMed
    Score: 0.023
  34. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. JAMA Netw Open. 2021 02 01; 4(2):e2037512.
    View in: PubMed
    Score: 0.023
  35. Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study. BMC Health Serv Res. 2020 Nov 11; 20(1):1030.
    View in: PubMed
    Score: 0.023
  36. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020 04; 23(4):e25484.
    View in: PubMed
    Score: 0.022
  37. Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada. Clin Infect Dis. 2020 03 03; 70(6):1176-1185.
    View in: PubMed
    Score: 0.022
  38. Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis. Clin Infect Dis. 2020 03 03; 70(6):1131-1138.
    View in: PubMed
    Score: 0.022
  39. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
    View in: PubMed
    Score: 0.022
  40. Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients. J Acquir Immune Defic Syndr. 2019 09 01; 82(1):71-80.
    View in: PubMed
    Score: 0.021
  41. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system. Int J STD AIDS. 2019 06; 30(7):689-695.
    View in: PubMed
    Score: 0.020
  42. Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people. BMJ Open. 2017 12 27; 7(12):e018121.
    View in: PubMed
    Score: 0.019
  43. A Flow-Based Model of the HIV Care Continuum in the United States. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):548-553.
    View in: PubMed
    Score: 0.018
  44. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):382-390.
    View in: PubMed
    Score: 0.018
  45. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis. 2016 11 01; 63(9):1160-1167.
    View in: PubMed
    Score: 0.017
  46. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. J Infect Dis. 2016 09 15; 214(6):862-72.
    View in: PubMed
    Score: 0.017
  47. Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California. Am J Public Health. 2016 07; 106(7):1211-3.
    View in: PubMed
    Score: 0.017
  48. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2016 Jan; 32(1):50-8.
    View in: PubMed
    Score: 0.016
  49. Leukoplakia, Oral Cavity Cancer Risk, and Cancer Survival in the U.S. Elderly. Cancer Prev Res (Phila). 2015 Sep; 8(9):857-63.
    View in: PubMed
    Score: 0.016
  50. Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr. 2015 Apr 01; 68(4):413-9.
    View in: PubMed
    Score: 0.015
  51. Strong agreement of nationally recommended retention measures from the Institute of Medicine and Department of Health and Human Services. PLoS One. 2014; 9(11):e111772.
    View in: PubMed
    Score: 0.015
  52. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014 Apr; 58(8):1185-9.
    View in: PubMed
    Score: 0.014
  53. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013; 8(12):e81355.
    View in: PubMed
    Score: 0.014
  54. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One. 2013; 8(11):e78952.
    View in: PubMed
    Score: 0.014
  55. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. J Infect Dis. 2013 Oct 15; 208(8):1240-9.
    View in: PubMed
    Score: 0.014
  56. Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States. AIDS Patient Care STDS. 2013 Aug; 27(8):442-9.
    View in: PubMed
    Score: 0.014
  57. Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):356-62.
    View in: PubMed
    Score: 0.013
  58. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013 Apr; 56(8):1174-82.
    View in: PubMed
    Score: 0.013
  59. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis. 2011 Sep 15; 204(6):893-901.
    View in: PubMed
    Score: 0.012
  60. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010 Jun 01; 50(11):1512-20.
    View in: PubMed
    Score: 0.011
  61. Acute viral hepatitis: modern knowledge. Pediatr Ann. 1977 May; 6(5):299-310.
    View in: PubMed
    Score: 0.004

© 2026 Kaiser Permanente

Your Privacy Choices